A detailed history of Sky View Investment Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 10,992 shares of AZN stock, worth $695,024. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,992
Previous 10,919 0.67%
Holding current value
$695,024
Previous $740,000 15.81%
% of portfolio
0.15%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$66.81 - $80.83 $4,877 - $5,900
73 Added 0.67%
10,992 $857,000
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $666,386 - $759,634
10,919 New
10,919 $740,000
Q3 2023

Nov 16, 2023

BUY
$64.85 - $71.7 $29,701 - $32,838
458 Added 5.66%
8,551 $579,000
Q2 2023

Aug 15, 2023

BUY
$69.91 - $75.81 $565,781 - $613,530
8,093 New
8,093 $579,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sky View Investment Advisors, LLC Portfolio

Follow Sky View Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky View Investment Advisors, LLC with notifications on news.